The global Macitentan Tablets market is projected to grow from US$ 2011 million in 2024 to US$ 4134 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Macitentan Tablets Market

Macitentan is currently the only ERA drug that has conclusive research evidence to support its ability to delay right ventricular remodeling. It is also the only ERA drug that currently has research data to support that a single drug can significantly reduce the risk of patient deterioration or death by 55%.

7. ERA drugs--ERA Drugs--ERA drugs (Endothelin Receptor Antagonists) are a class of drugs used to treat certain cardiovascular and pulmonary diseases. They relax blood vessels, lower blood pressure and improve blood flow by blocking the binding of endothelin, a potent vasoconstrictor, to its receptors.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Macitentan Tablets leading manufacturers including Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Shanghai Pharmaceutical Group, Jiangsu Yunyang Group Pharmaceutical, Mylan, Teva, etc., dominate supply; the top five capture approximately % of global revenue, with Johnson & Johnson leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Macitentan Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Macitentan Tablets Market Report

Report Metric	Details
Report Name	Macitentan Tablets Market
Accounted market size in 2024	US$ 2011 million
Forecasted market size in 2031	US$ 4134 million
CAGR	11.0%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital Clinic Other
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Shanghai Pharmaceutical Group, Jiangsu Yunyang Group Pharmaceutical, Mylan, Teva, Dr. Reddy's Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Macitentan Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Macitentan Tablets Market growing?

Ans: The Macitentan Tablets Market witnessing a CAGR of 11.0% during the forecast period 2025-2031.

What is the Macitentan Tablets Market size in 2031?

Ans: The Macitentan Tablets Market size in 2031 will be US$ 4134 million.

Who are the main players in the Macitentan Tablets Market report?

Ans: The main players in the Macitentan Tablets Market are Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Shanghai Pharmaceutical Group, Jiangsu Yunyang Group Pharmaceutical, Mylan, Teva, Dr. Reddy's Laboratories

What are the Application segmentation covered in the Macitentan Tablets Market report?

Ans: The Applications covered in the Macitentan Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Macitentan Tablets Market report?

Ans: The Types covered in the Macitentan Tablets Market report are Original Drug, Generic Drug

1 Study Coverage

1.1 Introduction to Macitentan Tablets: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Macitentan Tablets Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Market Segmentation by Application

1.3.1 Global Macitentan Tablets Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Macitentan Tablets Revenue Estimates and Forecasts 2020-2031

2.2 Global Macitentan Tablets Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Macitentan Tablets Sales Estimates and Forecasts 2020-2031

2.4 Global Macitentan Tablets Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Macitentan Tablets Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Macitentan Tablets Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Original Drug Market Size by Manufacturers

3.5.2 Generic Drug Market Size by Manufacturers

3.6 Global Macitentan Tablets Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Macitentan Tablets Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Macitentan Tablets Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Macitentan Tablets Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Macitentan Tablets Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Macitentan Tablets Sales and Revenue by Type (2020-2031)

6.4 North America Macitentan Tablets Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Macitentan Tablets Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Macitentan Tablets Sales and Revenue by Type (2020-2031)

7.4 Europe Macitentan Tablets Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Macitentan Tablets Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Macitentan Tablets Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Macitentan Tablets Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Macitentan Tablets Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Macitentan Tablets Sales and Revenue by Type (2020-2031)

9.4 Central and South America Macitentan Tablets Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Macitentan Tablets Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Macitentan Tablets Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Macitentan Tablets Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Macitentan Tablets Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Corporation Information

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Macitentan Tablets Product Models, Descriptions and Specifications

11.1.4 Johnson & Johnson Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Johnson & Johnson Macitentan Tablets Sales by Product in 2024

11.1.6 Johnson & Johnson Macitentan Tablets Sales by Application in 2024

11.1.7 Johnson & Johnson Macitentan Tablets Sales by Geographic Area in 2024

11.1.8 Johnson & Johnson Macitentan Tablets SWOT Analysis

11.1.9 Johnson & Johnson Recent Developments

11.2 Zhengda Tianqing

11.2.1 Zhengda Tianqing Corporation Information

11.2.2 Zhengda Tianqing Business Overview

11.2.3 Zhengda Tianqing Macitentan Tablets Product Models, Descriptions and Specifications

11.2.4 Zhengda Tianqing Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Zhengda Tianqing Macitentan Tablets Sales by Product in 2024

11.2.6 Zhengda Tianqing Macitentan Tablets Sales by Application in 2024

11.2.7 Zhengda Tianqing Macitentan Tablets Sales by Geographic Area in 2024

11.2.8 Zhengda Tianqing Macitentan Tablets SWOT Analysis

11.2.9 Zhengda Tianqing Recent Developments

11.3 Sinotherapeutics

11.3.1 Sinotherapeutics Corporation Information

11.3.2 Sinotherapeutics Business Overview

11.3.3 Sinotherapeutics Macitentan Tablets Product Models, Descriptions and Specifications

11.3.4 Sinotherapeutics Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Sinotherapeutics Macitentan Tablets Sales by Product in 2024

11.3.6 Sinotherapeutics Macitentan Tablets Sales by Application in 2024

11.3.7 Sinotherapeutics Macitentan Tablets Sales by Geographic Area in 2024

11.3.8 Sinotherapeutics Macitentan Tablets SWOT Analysis

11.3.9 Sinotherapeutics Recent Developments

11.4 Qilu Pharmaceutical

11.4.1 Qilu Pharmaceutical Corporation Information

11.4.2 Qilu Pharmaceutical Business Overview

11.4.3 Qilu Pharmaceutical Macitentan Tablets Product Models, Descriptions and Specifications

11.4.4 Qilu Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Qilu Pharmaceutical Macitentan Tablets Sales by Product in 2024

11.4.6 Qilu Pharmaceutical Macitentan Tablets Sales by Application in 2024

11.4.7 Qilu Pharmaceutical Macitentan Tablets Sales by Geographic Area in 2024

11.4.8 Qilu Pharmaceutical Macitentan Tablets SWOT Analysis

11.4.9 Qilu Pharmaceutical Recent Developments

11.5 Hangzhou Zhongmei Huadong Pharmaceutical

11.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information

11.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview

11.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Product Models, Descriptions and Specifications

11.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales by Product in 2024

11.5.6 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales by Application in 2024

11.5.7 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales by Geographic Area in 2024

11.5.8 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets SWOT Analysis

11.5.9 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments

11.6 Shanghai Xudong Haipu Pharmaceutical

11.6.1 Shanghai Xudong Haipu Pharmaceutical Corporation Information

11.6.2 Shanghai Xudong Haipu Pharmaceutical Business Overview

11.6.3 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Product Models, Descriptions and Specifications

11.6.4 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments

11.7 Shanghai Pharmaceutical Group

11.7.1 Shanghai Pharmaceutical Group Corporation Information

11.7.2 Shanghai Pharmaceutical Group Business Overview

11.7.3 Shanghai Pharmaceutical Group Macitentan Tablets Product Models, Descriptions and Specifications

11.7.4 Shanghai Pharmaceutical Group Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Shanghai Pharmaceutical Group Recent Developments

11.8 Jiangsu Yunyang Group Pharmaceutical

11.8.1 Jiangsu Yunyang Group Pharmaceutical Corporation Information

11.8.2 Jiangsu Yunyang Group Pharmaceutical Business Overview

11.8.3 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Product Models, Descriptions and Specifications

11.8.4 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Jiangsu Yunyang Group Pharmaceutical Recent Developments

11.9 Mylan

11.9.1 Mylan Corporation Information

11.9.2 Mylan Business Overview

11.9.3 Mylan Macitentan Tablets Product Models, Descriptions and Specifications

11.9.4 Mylan Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Mylan Recent Developments

11.10 Teva

11.10.1 Teva Corporation Information

11.10.2 Teva Business Overview

11.10.3 Teva Macitentan Tablets Product Models, Descriptions and Specifications

11.10.4 Teva Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Teva Recent Developments

11.11 Dr. Reddy's Laboratories

11.11.1 Dr. Reddy's Laboratories Corporation Information

11.11.2 Dr. Reddy's Laboratories Business Overview

11.11.3 Dr. Reddy's Laboratories Macitentan Tablets Product Models, Descriptions and Specifications

11.11.4 Dr. Reddy's Laboratories Macitentan Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Dr. Reddy's Laboratories Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Macitentan Tablets Industry Chain

12.2 Macitentan Tablets Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Macitentan Tablets Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Macitentan Tablets Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Macitentan Tablets Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Macitentan Tablets Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Hangzhou Zhongmei Huadong Pharmaceutical

Shanghai Xudong Haipu Pharmaceutical

Shanghai Pharmaceutical Group

Jiangsu Yunyang Group Pharmaceutical

Mylan NV

TEVA

Dr. Reddy’s Laboratories

List of Tables

Table 1. Global Macitentan Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Macitentan Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Macitentan Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Macitentan Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Macitentan Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Macitentan Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Macitentan Tablets Sales by Region (2020-2025) & (K Units)

Table 8. Global Macitentan Tablets Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Macitentan Tablets Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Macitentan Tablets Sales Share by Manufacturers (2020-2025)

Table 12. Global Macitentan Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Macitentan Tablets Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Macitentan Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macitentan Tablets as of 2024)

Table 16. Global Macitentan Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Macitentan Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Macitentan Tablets Manufacturing Base and Headquarters

Table 19. Global Macitentan Tablets Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Macitentan Tablets Sales by Type (2020-2025) & (K Units)

Table 23. Global Macitentan Tablets Sales by Type (2026-2031) & (K Units)

Table 24. Global Macitentan Tablets Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Macitentan Tablets Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Macitentan Tablets ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Macitentan Tablets Sales by Application (2020-2025) & (K Units)

Table 29. Global Macitentan Tablets Sales by Application (2026-2031) & (K Units)

Table 30. Macitentan Tablets High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Macitentan Tablets Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Macitentan Tablets Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Macitentan Tablets ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Macitentan Tablets Growth Accelerators and Market Barriers

Table 37. North America Macitentan Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Macitentan Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Macitentan Tablets Growth Accelerators and Market Barriers

Table 40. Europe Macitentan Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Macitentan Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Macitentan Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Macitentan Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Macitentan Tablets Growth Accelerators and Market Barriers

Table 45. Southeast Asia Macitentan Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Macitentan Tablets Investment Opportunities and Key Challenges

Table 47. Central and South America Macitentan Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Macitentan Tablets Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Macitentan Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Johnson & Johnson Corporation Information

Table 51. Johnson & Johnson Description and Major Businesses

Table 52. Johnson & Johnson Product Models, Descriptions and Specifications

Table 53. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Johnson & Johnson Sales Value Proportion by Product in 2024

Table 55. Johnson & Johnson Sales Value Proportion by Application in 2024

Table 56. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024

Table 57. Johnson & Johnson Macitentan Tablets SWOT Analysis

Table 58. Johnson & Johnson Recent Developments

Table 59. Zhengda Tianqing Corporation Information

Table 60. Zhengda Tianqing Description and Major Businesses

Table 61. Zhengda Tianqing Product Models, Descriptions and Specifications

Table 62. Zhengda Tianqing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Zhengda Tianqing Sales Value Proportion by Product in 2024

Table 64. Zhengda Tianqing Sales Value Proportion by Application in 2024

Table 65. Zhengda Tianqing Sales Value Proportion by Geographic Area in 2024

Table 66. Zhengda Tianqing Macitentan Tablets SWOT Analysis

Table 67. Zhengda Tianqing Recent Developments

Table 68. Sinotherapeutics Corporation Information

Table 69. Sinotherapeutics Description and Major Businesses

Table 70. Sinotherapeutics Product Models, Descriptions and Specifications

Table 71. Sinotherapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Sinotherapeutics Sales Value Proportion by Product in 2024

Table 73. Sinotherapeutics Sales Value Proportion by Application in 2024

Table 74. Sinotherapeutics Sales Value Proportion by Geographic Area in 2024

Table 75. Sinotherapeutics Macitentan Tablets SWOT Analysis

Table 76. Sinotherapeutics Recent Developments

Table 77. Qilu Pharmaceutical Corporation Information

Table 78. Qilu Pharmaceutical Description and Major Businesses

Table 79. Qilu Pharmaceutical Product Models, Descriptions and Specifications

Table 80. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Qilu Pharmaceutical Sales Value Proportion by Product in 2024

Table 82. Qilu Pharmaceutical Sales Value Proportion by Application in 2024

Table 83. Qilu Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 84. Qilu Pharmaceutical Macitentan Tablets SWOT Analysis

Table 85. Qilu Pharmaceutical Recent Developments

Table 86. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information

Table 87. Hangzhou Zhongmei Huadong Pharmaceutical Description and Major Businesses

Table 88. Hangzhou Zhongmei Huadong Pharmaceutical Product Models, Descriptions and Specifications

Table 89. Hangzhou Zhongmei Huadong Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Hangzhou Zhongmei Huadong Pharmaceutical Sales Value Proportion by Product in 2024

Table 91. Hangzhou Zhongmei Huadong Pharmaceutical Sales Value Proportion by Application in 2024

Table 92. Hangzhou Zhongmei Huadong Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 93. Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets SWOT Analysis

Table 94. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments

Table 95. Shanghai Xudong Haipu Pharmaceutical Corporation Information

Table 96. Shanghai Xudong Haipu Pharmaceutical Description and Major Businesses

Table 97. Shanghai Xudong Haipu Pharmaceutical Product Models, Descriptions and Specifications

Table 98. Shanghai Xudong Haipu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Shanghai Xudong Haipu Pharmaceutical Recent Developments

Table 100. Shanghai Pharmaceutical Group Corporation Information

Table 101. Shanghai Pharmaceutical Group Description and Major Businesses

Table 102. Shanghai Pharmaceutical Group Product Models, Descriptions and Specifications

Table 103. Shanghai Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Shanghai Pharmaceutical Group Recent Developments

Table 105. Jiangsu Yunyang Group Pharmaceutical Corporation Information

Table 106. Jiangsu Yunyang Group Pharmaceutical Description and Major Businesses

Table 107. Jiangsu Yunyang Group Pharmaceutical Product Models, Descriptions and Specifications

Table 108. Jiangsu Yunyang Group Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Jiangsu Yunyang Group Pharmaceutical Recent Developments

Table 110. Mylan Corporation Information

Table 111. Mylan Description and Major Businesses

Table 112. Mylan Product Models, Descriptions and Specifications

Table 113. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Mylan Recent Developments

Table 115. Teva Corporation Information

Table 116. Teva Description and Major Businesses

Table 117. Teva Product Models, Descriptions and Specifications

Table 118. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Teva Recent Developments

Table 120. Dr. Reddy's Laboratories Corporation Information

Table 121. Dr. Reddy's Laboratories Description and Major Businesses

Table 122. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications

Table 123. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Dr. Reddy's Laboratories Recent Developments

Table 125. Key Raw Materials Distribution

Table 126. Raw Materials Key Suppliers

Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 128. Milestones in Production Technology Evolution

Table 129. Distributors List

Table 130. Market Trends and Market Evolution

Table 131. Market Drivers and Opportunities

Table 132. Market Challenges, Risks, and Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Macitentan Tablets Product Picture

Figure 2. Global Macitentan Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Original Drug Product Picture

Figure 4. Generic Drug Product Picture

Figure 5. Global Macitentan Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Other

Figure 9. Macitentan Tablets Report Years Considered

Figure 10. Global Macitentan Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 12. Global Macitentan Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Macitentan Tablets Revenue Market Share by Region (2020-2031)

Figure 14. Global Macitentan Tablets Sales (2020-2031) & (K Units)

Figure 15. Global Macitentan Tablets Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Macitentan Tablets Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Macitentan Tablets Sales Volume Market Share in 2024

Figure 18. Global Macitentan Tablets Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Original Drug Revenue Market Share by Manufacturer in 2024

Figure 21. Generic Drug Revenue Market Share by Manufacturer in 2024

Figure 22. Global Macitentan Tablets Sales Market Share by Type (2020-2031)

Figure 23. Global Macitentan Tablets Revenue Market Share by Type (2020-2031)

Figure 24. Global Macitentan Tablets Sales Market Share by Application (2020-2031)

Figure 25. Global Macitentan Tablets Revenue Market Share by Application (2020-2031)

Figure 26. North America Macitentan Tablets Sales YoY (2020-2031) & (K Units)

Figure 27. North America Macitentan Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Macitentan Tablets Sales Revenue (US$ Million) in 2024

Figure 29. North America Macitentan Tablets Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Macitentan Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Macitentan Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Macitentan Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Macitentan Tablets Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Macitentan Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Macitentan Tablets Sales Revenue (US$ Million) in 2024

Figure 39. Europe Macitentan Tablets Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Macitentan Tablets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Macitentan Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Macitentan Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 44. France Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Macitentan Tablets Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Macitentan Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Macitentan Tablets Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Macitentan Tablets Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Macitentan Tablets Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Macitentan Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Macitentan Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 59. India Macitentan Tablets Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Macitentan Tablets Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Macitentan Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Macitentan Tablets Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Macitentan Tablets Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Macitentan Tablets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Macitentan Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Macitentan Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Macitentan Tablets Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Macitentan Tablets Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Macitentan Tablets Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Macitentan Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Macitentan Tablets Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Macitentan Tablets Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Macitentan Tablets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Macitentan Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Macitentan Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Macitentan Tablets Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Macitentan Tablets Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Macitentan Tablets Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Macitentan Tablets Revenue (2020-2025) & (US$ Million)

Figure 80. Macitentan Tablets Industry Chain Mapping

Figure 81. Regional Macitentan Tablets Manufacturing Base Distribution (%)

Figure 82. Global Macitentan Tablets Production Market Share by Region (2020-2031)

Figure 83. Macitentan Tablets Production Process

Figure 84. Regional Macitentan Tablets Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-18T17751

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Pioglitazone Hydrochloride Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10K20152

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global FIC Single-target Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-15K17940

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Macitentan Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-37W17851

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Macitentan Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-37W17851

Global Macitentan Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Macitentan Tablets Market Size

Macitentan Tablets Market

Report Includes:

Scope of Macitentan Tablets Market Report

Chapter Outline

FAQ for this report

How fast is Macitentan Tablets Market growing?

What is the Macitentan Tablets Market size in 2031?

Who are the main players in the Macitentan Tablets Market report?

What are the Application segmentation covered in the Macitentan Tablets Market report?

What are the Type segmentation covered in the Macitentan Tablets Market report?

FEATURED COMPANIES

RELATED REPORTS